共 8 条
[1]
Explaining the decrease in U.S.deaths from coronary disease,1980—2000. Ford ES,Ajani UA,Croft JB,et al. The New England Journal of Medicine . 2007
[2]
Heart disease and stroke statistics--2010 update:a report from the American Heart Association. Lloyd-Jones D,,Adams RJ,Brown TM,et al. Circulation . 2010
[3]
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey[J] . Salim Yusuf,Shofiqul Islam,Clara K Chow,Sumathy Rangarajan,Gilles Dagenais,Rafael Diaz,Rajeev Gupta,Roya Kelishadi,Romaina Iqbal,Alvaro Avezum,Annamarie Kruger,Raman Kutty,Fernando Lanas,Liu Lisheng,Li Wei,Patricio Lopez-Jaramillo,Aytekin Oguz,Omar Rahman,Hany Swidan,Khalid Yusoff,Witold Zatonski,Annika R
[4]
中国成人血脂异常防治指南[J]. 中华心血管病杂志. 2007(05)
[5]
我国高胆固醇血症患者临床控制状况变化趋势2000年与2004—2006年达标率比较[J]. 赵连成,梁立荣,陈祚,田秀芝,武阳丰. 中华心血管病杂志. 2007(09)
[7]
ESC/EAS Guidelines for the management of dyslipidaemias:the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC ) and the European Atherosclerosis Society (EAS). Reiner Z,Catapano AL,De Backer G,et al. European Heart Journal . 2011
[8]
Use of secondary prevention drugs for cardiovascular disease in the community in high-income,middle-income and low-income countries (the PURE Study):a prospective epidemiological survey. Yusuf S,Islam S,Chow CK,et al. The Lancet . 2011